# Naloxegol in Cancer Opioid-Induced Constipation

> **NCT02745353** · PHASE2 · TERMINATED · sponsor: **Joseph Ma** · enrollment: 7 (actual)

## Conditions studied

- Constipation

## Interventions

- **DRUG:** naloxegol

## Key facts

- **NCT ID:** NCT02745353
- **Lead sponsor:** Joseph Ma
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2016-05
- **Primary completion:** 2017-06-22
- **Final completion:** 2017-06-22
- **Target enrollment:** 7 (ACTUAL)
- **Why stopped:** Couldn't enough accrue patients
- **Last updated:** 2019-12-09

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02745353

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02745353, "Naloxegol in Cancer Opioid-Induced Constipation". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT02745353. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*